These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 9231050)

  • 1. A CTLA-4 gene polymorphism is associated with both Graves disease and autoimmune hypothyroidism.
    Kotsa K; Watson PF; Weetman AP
    Clin Endocrinol (Oxf); 1997 May; 46(5):551-4. PubMed ID: 9231050
    [TBL] [Abstract][Full Text] [Related]  

  • 2. No evidence for allelic association of a human CTLA-4 promoter polymorphism with autoimmune thyroid disease in either population-based case-control or family-based studies.
    Heward JM; Allahabadia A; Carr-Smith J; Daykin J; Cockram CS; Gordon C; Barnett AH; Franklyn JA; Gough SC
    Clin Endocrinol (Oxf); 1998 Sep; 49(3):331-4. PubMed ID: 9861324
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of a microsatellite polymorphism of the cytotoxic T-lymphocyte antigen-4 gene in patients with vitiligo.
    Kemp EH; Ajjan RA; Waterman EA; Gawkrodger DJ; Cork MJ; Watson PF; Weetman AP
    Br J Dermatol; 1999 Jan; 140(1):73-8. PubMed ID: 10215771
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A cytotoxic T lymphocyte antigen-4 (CTLA-4) gene polymorphism is associated with autoimmune Addison's disease in English patients.
    Kemp EH; Ajjan RA; Husebye ES; Peterson P; Uibo R; Imrie H; Pearce SH; Watson PF; Weetman AP
    Clin Endocrinol (Oxf); 1998 Nov; 49(5):609-13. PubMed ID: 10197076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relation of three polymorphisms of the CTLA-4 gene in patients with Graves' disease.
    Kouki T; Gardine CA; Yanagawa T; Degroot LJ
    J Endocrinol Invest; 2002 Mar; 25(3):208-13. PubMed ID: 11936461
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CTLA-4 gene polymorphism associated with Graves' disease in a Caucasian population.
    Yanagawa T; Hidaka Y; Guimaraes V; Soliman M; DeGroot LJ
    J Clin Endocrinol Metab; 1995 Jan; 80(1):41-5. PubMed ID: 7829637
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of autoimmune thyroid disease with a microsatellite marker for the thyrotropin receptor gene and CTLA-4 in a Japanese population.
    Sale MM; Akamizu T; Howard TD; Yokota T; Nakao K; Mori T; Iwasaki H; Rich SS; Jennings-Gee JE; Yamada M; Bowden DW
    Proc Assoc Am Physicians; 1997 Sep; 109(5):453-61. PubMed ID: 9285944
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polymorphism of the CTLA-4 gene is associated with autoimmune hypothyroidism in the United Kingdom.
    Nithiyananthan R; Heward JM; Allahabadia A; Franklyn JA; Gough SC
    Thyroid; 2002 Jan; 12(1):3-6. PubMed ID: 11842815
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polymorphism in the promoter and exon 1 of the cytotoxic T lymphocyte antigen-4 gene associated with autoimmune thyroid disease in Koreans.
    Park YJ; Chung HK; Park DJ; Kim WB; Kim SW; Koh JJ; Cho BY
    Thyroid; 2000 Jun; 10(6):453-9. PubMed ID: 10907987
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CTLA-4 gene polymorphisms in Tunisian patients with Graves' disease.
    Hadj Kacem H; Bellassoued M; Bougacha-Elleuch N; Abid M; Ayadi H
    Clin Immunol; 2001 Dec; 101(3):361-5. PubMed ID: 11726229
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CTLA-4 gene A-G polymorphism and childhood Graves' disease.
    Yung E; Cheng PS; Fok TF; Wong GW
    Clin Endocrinol (Oxf); 2002 May; 56(5):649-53. PubMed ID: 12030917
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CT60 single nucleotide polymorphisms of the cytotoxic T-lymphocyte-associated antigen-4 gene region is associated with Graves' disease in an Italian population.
    Petrone A; Giorgi G; Galgani A; Alemanno I; Corsello SM; Signore A; Di Mario U; Nisticò L; Cascino I; Buzzetti R
    Thyroid; 2005 Mar; 15(3):232-8. PubMed ID: 15785242
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Limited genetic susceptibility to severe Graves' ophthalmopathy: no role for CTLA-4 but evidence for an environmental etiology.
    Villanueva R; Inzerillo AM; Tomer Y; Barbesino G; Meltzer M; Concepcion ES; Greenberg DA; MacLaren N; Sun ZS; Zhang DM; Tucci S; Davies TF
    Thyroid; 2000 Sep; 10(9):791-8. PubMed ID: 11041456
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A study of the association between a polymorphism in the CTLA-4 gene and postpartum thyroiditis.
    Waterman EA; Watson PF; Lazarus JH; Parkes AB; Darke C; Weetman AP
    Clin Endocrinol (Oxf); 1998 Aug; 49(2):251-5. PubMed ID: 9828915
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The influence of the exon 1 polymorphism of the cytotoxic T lymphocyte antigen 4 gene on thyroid antibody production in patients with newly diagnosed Graves' disease.
    Zaletel K; Krhin B; Gaberscek S; Pirnat E; Hojker S
    Thyroid; 2002 May; 12(5):373-6. PubMed ID: 12097196
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CTLA-4 gene polymorphism and its association with Graves' disease in the Lebanese population.
    Nakkash-Chmaisse H; Makki RF; Abdelhamid E; Fakhoury H; Salti NN; Salti I
    Eur J Immunogenet; 2004 Jun; 31(3):141-3. PubMed ID: 15182328
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The development of Graves' disease and the CTLA-4 gene on chromosome 2q33.
    Heward JM; Allahabadia A; Armitage M; Hattersley A; Dodson PM; Macleod K; Carr-Smith J; Daykin J; Daly A; Sheppard MC; Holder RL; Barnett AH; Franklyn JA; Gough SC
    J Clin Endocrinol Metab; 1999 Jul; 84(7):2398-401. PubMed ID: 10404810
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CTLA4 gene polymorphism confers susceptibility to Graves' disease in Japanese.
    Yanagawa T; Taniyama M; Enomoto S; Gomi K; Maruyama H; Ban Y; Saruta T
    Thyroid; 1997 Dec; 7(6):843-6. PubMed ID: 9459626
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CTLA-4 gene polymorphism at position 49 in exon 1 reduces the inhibitory function of CTLA-4 and contributes to the pathogenesis of Graves' disease.
    Kouki T; Sawai Y; Gardine CA; Fisfalen ME; Alegre ML; DeGroot LJ
    J Immunol; 2000 Dec; 165(11):6606-11. PubMed ID: 11086105
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence for a Graves' disease susceptibility locus at chromosome Xp11 in a United Kingdom population.
    Imrie H; Vaidya B; Perros P; Kelly WF; Toft AD; Young ET; Kendall-Taylor P; Pearce SH
    J Clin Endocrinol Metab; 2001 Feb; 86(2):626-30. PubMed ID: 11158020
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.